The stock price of GRI Bio Inc (NASDAQ: GRI) has surged by 14.13 when compared to previous closing price of 0.42, but the company has seen a -1.09% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-09-05 that LA JOLLA, CA, Sept. 05, 2024 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, PhD, Chief Executive Officer will present at the H.C. Wainwright 26 th Annual Global Investment Conference being held September 9-11, 2024 in New York, NY.
Is It Worth Investing in GRI Bio Inc (NASDAQ: GRI) Right Now?
The stock has a 36-month beta value of -1.71. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GRI is 2.92M, and at present, short sellers hold a 15.01% of that float. On September 24, 2024, the average trading volume of GRI was 602.49K shares.
GRI’s Market Performance
GRI stock saw a decrease of -1.09% in the past week, with a monthly decline of -5.74% and a quarterly a decrease of -83.85%. The volatility ratio for the week is 9.48%, and the volatility levels for the last 30 days are 9.54% for GRI Bio Inc (GRI). The simple moving average for the last 20 days is -4.40% for GRI stock, with a simple moving average of -95.45% for the last 200 days.
GRI Trading at -34.64% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.70% of loss for the given period.
Volatility was left at 9.54%, however, over the last 30 days, the volatility rate increased by 9.48%, as shares sank -8.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -72.64% lower at present.
During the last 5 trading sessions, GRI fell by -4.10%, which changed the moving average for the period of 200-days by -99.01% in comparison to the 20-day moving average, which settled at $0.4997. In addition, GRI Bio Inc saw -98.63% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRI
Current profitability levels for the company are sitting at:
- -1.6 for the present operating margin
- 1.0 for the gross margin
The net margin for GRI Bio Inc stands at -1.53. The total capital return value is set at -1.79. Equity return is now at value -189.06, with -130.64 for asset returns.
Based on GRI Bio Inc (GRI), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -79.54.
Currently, EBITDA for the company is -11.33 million with net debt to EBITDA at 0.72. When we switch over and look at the enterprise to sales, we see a ratio of -0.9. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.11.
Conclusion
To sum up, GRI Bio Inc (GRI) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
